Down-regulation of Lyn/Src family kinases in these AML cells by siRNA or small molecule inhibitors substantially ameliorated their growth in vitro and tumor establishment and growth in vivo, as well as phosphorylation of important down-stream FLT3/IDT mediators such as STAT5 [85]. This evidence concerns the gene FLT3 and acute myeloid leukemia.